All stock lists
Tencent Music Entertainment Group (New York Stock Exchange:TME)
CN · Delayed Price · Currency is USD
Communication Services · Internet Content & Information
8.48-0.03 (-0.35%)
Market cap
$12.5B
Health Score
Analyst consensus
Listed since
Dec 12, 2018
Website
Insider Score
––Not scored
TME Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TME analyst forecast
TME analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TME 12-month price target
No published price targets in the last 12 months.
Best analysts covering TME
- Morgan Stanley100%success rate · 3 calls
- Mizuho88%success rate · 8 calls
- Benchmark88%success rate · 8 calls
- Barclays0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TME analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | China Renaissance | Hold | — | — | Downgraded | 2026-08-12 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-08-12 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-05-14 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-05-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-19 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-03-18 |
| — | UBS | Neutral | — | — | Downgraded | 2026-03-18 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-03-18 |
| — | Benchmark | Hold | — | — | Downgraded | 2026-03-18 |
| — | Macquarie | Neutral | — | — | Downgraded | 2026-03-05 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-12-22 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-11-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-12 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-08-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-08-12 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-08-12 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-03-19 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2025-01-21 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2024-09-25 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-08-14 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-08-14 |
| — | Mizuho | Outperform | — | — | Reiterated | 2024-08-14 |
| — | Mizuho | Buy | — | — | Reiterated | 2024-05-14 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-05-14 |
| — | Mizuho | Buy | — | — | Reiterated | 2024-05-10 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-03-20 |
| — | HSBC | Hold | — | — | Reiterated | 2024-03-20 |
| — | Mizuho | Buy | — | — | Reiterated | 2024-03-20 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-03-20 |
| — | Citigroup | Buy | — | — | Upgraded | 2024-03-20 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2024-03-20 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-03-20 |
| — | UBS | Buy | — | — | Upgraded | 2024-01-24 |
| — | Mizuho | Buy | — | — | Reiterated | 2024-01-17 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2023-11-16 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-11-15 |
| — | B of A Securities | Buy | — | — | Reiterated | 2023-08-16 |
| — | Citigroup | Neutral | — | — | Reiterated | 2023-08-16 |
| — | Citigroup | Neutral | — | — | Downgraded | 2023-07-31 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2023-07-26 |
| — | HSBC | Hold | — | — | Reiterated | 2023-07-20 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-05-18 |
| — | Citigroup | Buy | — | — | Upgraded | 2023-05-18 |
| — | Mizuho | Buy | — | — | Reiterated | 2023-05-17 |
| — | China Renaissance | Buy | — | — | Upgraded | 2023-05-17 |
| — | Citigroup | Buy | — | — | Upgraded | 2023-05-17 |
| — | Macquarie | Neutral | — | — | Upgraded | 2023-05-17 |
| — | HSBC | Buy | — | — | Reiterated | 2023-05-17 |
| — | Mizuho | Buy | — | — | Reiterated | 2023-04-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-03-22 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-01-09 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2022-12-01 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2022-11-21 |
| — | Benchmark | Buy | — | — | Upgraded | 2022-11-16 |
| — | Goldman Sachs | Sell | — | — | Downgraded | 2022-02-18 |
| — | China Renaissance | Hold | — | — | Downgraded | 2022-01-20 |
| — | Benchmark | Hold | — | — | Reiterated | 2021-12-28 |
| — | UBS | Neutral | — | — | Downgraded | 2021-11-15 |
| — | Loop Capital | Hold | — | — | Downgraded | 2021-09-13 |
| — | Needham | Buy | — | — | Reiterated | 2021-08-19 |
TME earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-17 | 0.23 | 0.17 | $1.20B | $178.8M |
| 2026-05-12 | 0.21 | 0.21 | $1.14B | $168.0M |
| 2026-08-11 | 0.24 | 0.25 | $1.30B | $1.32B |
| 2026-11-17 | 0.22 | 0.00 | $1.36B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.